Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Spinal SGK1 is involved in the development of morphine tolerance through NF-kB p65/NMDAR signaling

Sep. 13, 2019

AgeneBio receives support for GABA-A alpha5 PAM program

Sep. 13, 2019

Adamed Pharma discovers dual 5-HT2A and 5-HT6 receptor antagonists

Sep. 13, 2019

LCGA-17 peptide shows anxiolytic and antidepressant activity in zebrafish

Sep. 13, 2019

Navitor presents data from phase I program of NV-5138

Sep. 13, 2019

Prevail Therapeutics advances development of PR-001 for Parkinson's and Gaucher's diseases

Sep. 12, 2019

Ocrelizumab in RRMS: CASTING study phase III results presented

Sep. 12, 2019

New analgesics synthesized at Daiichi Sankyo

Sep. 12, 2019

Transgenic CYP2C19 mouse as a new animal model for hyperdopaminergism-induced hyperkinesia

Sep. 12, 2019

Tiziana presents phase I results for nasal foralumab

Sep. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...